DataString Consulting Company Logo
DataString Consulting Company Logo
Neurovascular Devices Market
Home»Recent Reports»Neurovascular Devices Market

Neurovascular Devices Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1801076, Published - January 2025

Segmented in Product Type (Coiling Assist, Flow Diversion, Neurothrombectomy, Support), Technology (Embolization & Coiling, Carotid Artery Stenting, Neurothrombectomy), Material, End User and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Neurovascular Devices Market Outlook

The Neurovascular Devices market is undergoing a shift thanks to remarkable progress in biomedical engineering and neuroscience fields leading to groundbreaking advancements in neurology and neurosurgery practices. The market, for Neurovascular devices was estimated at $3.9 billion in 2024. It is anticipated to increase to $5.3 billion by 2030 with projections indicating a growth to around $7.0 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 5.5% over the forecast period. These innovative devices are becoming more widespread. Are playing a crucial role in reshaping the medical landscape by allowing healthcare providers to overcome challenges that were previously unimaginable. Their impact extends beyond the healthcare sector. Influences various aspects of society, by improving patient care and enhancing healthcare system effectiveness.


Neurovascular devices cover a range of medical tools created to address and manage intricate vascular conditions in the brain and spine with precision and care. These devices utilize miniaturized technologies that play a crucial role in treating challenging neurovascular issues, like stroke and aneurysms.


Market Size Forecast & Key Insights

2019
$3.9B2024
2029
$6.6B2034

Absolute Growth Opportunity = $2.7B

The Neurovascular Devices market is projected to grow from $3.9 billion in 2024 to $6.6 billion in 2034. This represents a CAGR of 5.5%, reflecting rising demand across Stroke Management, Carotid Artery Stenosis Therapy and Intracranial Aneurysm Treatment.

The Neurovascular Devices market is set to add $2.7 billion between 2024 and 2034, with manufacturer targeting Flow Diversion & Neurothrombectomy Product Type projected to gain a larger market share.

With Increased incidence of neurovascular diseases, and Advancements in technology, Neurovascular Devices market to expand 71% between 2024 and 2034.

Opportunities in the Neurovascular Devices Market

Bioresorbable / Bio-degradable Stents

A rising pattern in the field of neurovascular devices involves the creation of stents that are bioresorbable or biodegradable in nature. These specialized devices are engineered to dissolve once their intended function is fulfilled thereby diminishing the potential, for enduring complications linked to permanent neurovascular devices.

Advancements in Robotics and Enhancement in Telemedicine

The incorporation of robotics in the field of Neurovascular Devices presents an opportunity that has yet to be fully explored. With the progress in technology the use of assistance is proving to be beneficial in improving the accuracy and safety of neurovascular surgeries leading to a decrease in potential complications. This advancement, in technology is expected to revolutionize the industry and offer an avenue for growth.

The introduction of telemedicine in the healthcare field presents an opportunity for its utilization in the neurovascular devices market as well. Analyszing condition remotely and offering prompt responses to potential neurovascular issues are key benefits of telemedicines integration, into neurovascular devices. This incorporation could potentially fuel market expansion in this sector.

Growth Opportunities in North America and Europe

Europe Outlook

Europe stands as the largest market for Neurovascular Devices due to factors such as a growing elderly population and an increase in cases of neurovascular diseases alongside a robust healthcare infrastructure in the region that supports this growth trajectory. The competitive landscape in Europe is marked by the presence of industry players with established distribution channels. Additionally the market is bolstered by government funding and research support which not only drive market growth but also create avenues for further expansion, within the region.

North America Outlook

The Neurovascular Devices market in North America is at the forefront globally thanks to factors like the occurrence of neurovascular ailments and top tier healthcare facilities along with prominent market players contributing to fierce competition marked by ongoing innovation and regulatory nods. A heightened understanding of healthcare and the benefits of Neurovascular Devices presents enticing growth prospects, in this region.

North America Outlook

The Neurovascular Devices market in North America is at the forefront globally thanks to factors like the occurrence of neurovascular ailments and top tier healthcare facilities along with prominent market players contributing to fierce competition marked by ongoing innovation and regulatory nods. A heightened understanding of healthcare and the benefits of Neurovascular Devices presents enticing growth prospects, in this region.

Europe Outlook

Europe stands as the largest market for Neurovascular Devices due to factors such as a growing elderly population and an increase in cases of neurovascular diseases alongside a robust healthcare infrastructure in the region that supports this growth trajectory. The competitive landscape in Europe is marked by the presence of industry players with established distribution channels. Additionally the market is bolstered by government funding and research support which not only drive market growth but also create avenues for further expansion, within the region.

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, Japan, China, United Kingdom are expected to grow at 3.6% to 5.3% CAGR

2

Emerging Markets : Brazil, India, South Africa are expected to grow at 6.3% to 7.6% CAGR

Market Analysis Chart

The neurovascular devices market is impacted by factors that shape its current status and future direction collaboratively. There are factors driving this industry such as technological advancements leading to more effective and less invasive treatments for cerebral disorders. The increasing prevalence of disorders and the growing awareness, about neurovascular treatment also play significant roles in influencing this markets dynamics.

Recent Developments and Technological Advancement

December 2024

Johnson & Johnson has unveiled a bio absorbable stent, for treating neurovascular conditions. This addition enriches their range of products. Underscores their groundbreaking approach to patient well being.

September 2024

Medtronic introduced the NeuroForm Atlas Stent System as a significant advancement, in neurovascular care.

June 2024

Stryker Corporation acquired a startup specializing in AI powered neurovascular diagnostics as part of their move, towards integrating AI and ML into treatment strategies.

The worldwide Neurovascular Devices market has been steadily. Is considered a highly promising and rapidly advancing sector within the healthcare field. The focus in advancements has been primarily on technological enhancements leading to more precise devices and customized tools for patients. An important trend observed in this area is the move, towards invasive procedures as they are favored for their ability to reduce discomfort and promote faster recovery times.

Impact of Industry Transitions on the Neurovascular Devices Market

As a core segment of the Medical Device industry, the Neurovascular Devices market develops in line with broader industry shifts. Over recent years, transitions such as Increased Adoption of Neurovascular Devices and Technological Advancements Transforming The Field have redefined priorities across the Medical Device sector, influencing how the Neurovascular Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Increased Adoption of Neurovascular Devices:

The neurovascular devices sector is undergoing a transformation as there is a rising trend of adopting and utilizing these devices worldwide. This change is mainly attributed to the increasing prevalence of conditions like cerebral aneurysms and ischemic strokes among people. As a result of this development in healthcare technology and awareness about these disorders many medical facilities are upgrading their equipment with these state of the art devices leading to growth, in the market overall.

2

Technological Advancements Transforming The Field:

The integration of state of the art technologies into neurovascular devices marks a shift within this sector. Healthcare device manufacturers are currently designing products that boast capabilities, like improved maneuverability upgraded material composition to enhance flexibility and strength and alignment with the most recent neuro imaging methods.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Medical Device industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Medical Device industry cascade into the Neurovascular Devices market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Increased Incidence of Neurovascular Diseases, and Rising Healthcare Expenditure

The rising occurrence of conditions like brain aneurysms narrowing of blood vessels and strokes worldwide plays a crucial role in driving the need for advanced neurovascular equipment. State of the art devices are also essential, for treatments thus fueling the expansion of the market.
Healthcare costs are also on the uptrend globally which is also leading to an utilization of neurovascular devices across different medical treatments sectors. Boosted support from both public and private entities towards hospital neurology divisions could also pave the way for growth prospects, in the neurovascular devices sector.
Progress in the manufacturing of neurovascular devices using technology has also led to the creation of devices that are also more effective and long lasting with improved reliability as well. These advancements focus on improving safety and precision during procedures while also cutting down on recovery time significantly. Ultimately playing a key role, in driving market growth.

Restraint: Stringent Regulatory Policies

Strict regulations and approval procedures for neurovascular devices pose a challenge in the market as they demand considerable time and resources for compliance tasks that can impact product development timelines and market launches. The unique nature and intricate design of these devices attract examination leading to potential obstacles, in entering and expanding in the market which ultimately could impede growth and advancement in the neurovascular device sector over time.

Challenge: High Cost of Devices and Procedures

One limitation could be the significant expense of neurovascular tools and associated treatments. Their distinct and intricate structure incorporates a range of parts and technologies that ultimately impact the ultimate cost of these tools.

Supply Chain Landscape

Raw Material Acquisition

SGS S.A.

Bureau Veritas SA

Component Manufacturing

Stryker Corporation

Medtronic

Boston Scientific Corporation

Device Assembly & Testing
Johnson & Johnson Services Inc. / Smith & Nephew PLC
Distribution & End User Applications
B. Braun Melsungen AG / Cardinal Health
Raw Material Acquisition

SGS S.A.

Bureau Veritas SA

Component Manufacturing

Stryker Corporation

Medtronic

Boston Scientific Corporation

Device Assembly & Testing

Johnson & Johnson Services Inc.

Smith & Nephew PLC

Distribution & End User Applications

B. Braun Melsungen AG

Cardinal Health

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading ProvidersProvider Strategies
Stroke Treatment
Healthcare
Stryker Corporation
The company is centered around technological advancements and innovation, focusing on creating user-friendly devices that can help speed up the process of treating strokes. It also emphasizes expanding its network of service in different countries around the world.
Cerebral Aneurysm
Healthcare
Medtronic
Medtronic's strategy involves extensive research and development investment to develop new technologies and improve the effectiveness of their neurovascular devices. They are also focused on strategic acquisitions to strengthen their product portfolio and bolster market position.
Carotid Artery Stenting
Healthcare
Boston Scientific Corporation
Boston Scientific is dedicated to advancing their technological platforms, including the development of new stenting devices. They are also focused on clinician training and education to promote the optimal use of their products.
Spinal Cord Stimulation
Healthcare
Johnson & Johnson
Johnson & Johnson is focused on creating comprehensive healthcare solutions that integrate pharmaceutical, medical device, and consumer sectors. They have a commitment to innovation in order to develop and synthesize new neurovascular devices for disease treatment.

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Neurovascular Devices market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Neurovascular Devices in Carotid Artery Stenosis Therapy, Stroke Management and Intracranial Aneurysm Treatment

Carotid Artery Stenosis Therapy

Neurovascular devices are increasingly being employed in carotid artery stenosis therapy to prevent the occurrence of strokes. Techniques involving carotid artery stenting typically use these devices to widen the narrowed artery and ensure smooth blood flow.

Stroke Management

Neurovascular devices show promise in the treatment of strokes by aiding in clot removal procedures and brain aneurysms coiling processes as well as carotid artery stenting to prevent additional brain damage post stroke occurrence They offer better patient outcomes by delivering tailored therapy promptly and effectively One notable industry player, in this sector is Stryker Corporation

Intracranial Aneurysm Treatment

Neurovascular devices are an approach to treating intracranial aneurysms that offer a safer alternative, to conventional surgeries and help patients recover more quickly with fewer complications involved in the process Flow diverters and coil systems are commonly utilized to close off the aneurysms and prevent them from bursting Medtronic stands out as a leading provider of these innovative treatment options

Neurovascular Devices vs. Substitutes:
Performance and Positioning Analysis

Neurovascular devices provide less invasive treatments in comparison to other surgical procedures showing promising growth prospects in the market due to their effectiveness, in stroke prevention and cerebrovascular disease management.

Neurovascular Devices
  • Cerebrospinal Fluid Management Devices /
  • Intracranial Pressure Monitoring Devices
    High precision, minimally invasive nature
    High cost, requirement for skilled professionals
    Non-invasive treatment options, Broad accessibility
    Limited effectiveness in severe cases, Risk of misdiagnosis

Neurovascular Devices vs. Substitutes:
Performance and Positioning Analysis

Neurovascular Devices

  • High precision, minimally invasive nature
  • High cost, requirement for skilled professionals

Cerebrospinal Fluid Management Devices / Intracranial Pressure Monitoring Devices / neurostimulation devices

  • Non-invasive treatment options, Broad accessibility
  • Limited effectiveness in severe cases, Risk of misdiagnosis

Neurovascular devices provide less invasive treatments in comparison to other surgical procedures showing promising growth prospects in the market due to their effectiveness, in stroke prevention and cerebrovascular disease management.

Loading...

Research Methodology

This market research methodology defines the Neurovascular Devices market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Medical Device ecosystem, we analyze Neurovascular Devices across Hospitals, Neurology Clinics, and Ambulatory Surgical Centers Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Medtronic plc, Stryker Corporation, and Johnson & Johnson by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Acquisition, Component Manufacturing, and Device Assembly & Testing. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Medical Device revenues to estimate the Neurovascular Devices segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Acquisition (SGS S.A., Bureau Veritas SA), Component Manufacturing (Stryker Corporation, Medtronic), and Device Assembly & Testing. Our parallel substitute analysis examines Cerebrospinal Fluid Management Devices, Intracranial Pressure Monitoring Devices, and neurostimulation devices, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Medtronic plc, Stryker Corporation, and Johnson & Johnson, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Neurovascular Devices market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Neurovascular Devices Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 4.1 billion
Revenue Forecast in 2034USD 6.6 billion
Growth RateCAGR of 5.5% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 20243.9 billion
Growth OpportunityUSD 2.7 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 20243.9 billion USD
Market Size 20274.5 billion USD
Market Size 20295.1 billion USD
Market Size 20305.3 billion USD
Market Size 20346.6 billion USD
Market Size 20357.0 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredProduct Type, Technology, Material, End User
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledMedtronic plc, Stryker Corporation, Johnson & Johnson, Abbott Laboratories, Terumo Corporation, Penumbra Inc., MicroPort Scientific Corporation, Merit Medical Systems Inc., W. L. Gore & Associates Inc., Integer Holdings Corporation, B. Braun Melsungen AG and Boston Scientific Corporation
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Neurovascular Devices Market Size, Opportunities & Strategic Insights, by Product Type

4.1Coiling Assist
4.2Flow Diversion
4.3Neurothrombectomy
4.4Support
Chapter 5

Neurovascular Devices Market Size, Opportunities & Strategic Insights, by Technology

5.1Embolization & Coiling
5.2Carotid Artery Stenting
5.3Neurothrombectomy
Chapter 6

Neurovascular Devices Market Size, Opportunities & Strategic Insights, by Material

6.1Nitinol
6.2Platinum
6.3Cobalt-Chromium
6.4Stainless Steel
Chapter 7

Neurovascular Devices Market Size, Opportunities & Strategic Insights, by End User

7.1Hospitals
7.2Neurology Clinics
7.3Ambulatory Surgical Centers
7.4Others
Chapter 8

Neurovascular Devices Market, by Region

8.1North America Neurovascular Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Neurovascular Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Neurovascular Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Neurovascular Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Neurovascular Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Neurovascular Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1Medtronic plc
9.2.2Stryker Corporation
9.2.3Johnson & Johnson
9.2.4Abbott Laboratories
9.2.5Terumo Corporation
9.2.6Penumbra Inc.
9.2.7MicroPort Scientific Corporation
9.2.8Merit Medical Systems Inc.
9.2.9W. L. Gore & Associates Inc.
9.2.10Integer Holdings Corporation
9.2.11B. Braun Melsungen AG
9.2.12Boston Scientific Corporation